You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Empagliflozin in Patients with Chronic Kidney Disease
|
|---|---|
| Published in |
New England Journal of Medicine, November 2022
|
| DOI | 10.1056/nejmoa2204233 |
| Pubmed ID | |
| Authors |
The EMPA-KIDNEY Collaborative Group, William G. Herrington, Natalie Staplin, Christoph Wanner, Jennifer B. Green, Sibylle J. Hauske, Jonathan R. Emberson, David Preiss, Parminder Judge, Kaitlin J. Mayne, Sarah Y.A. Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K. Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P. Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine R. Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J. Landray, Colin Baigent, Richard Haynes |
X Demographics
The data shown below were collected from the profiles of 1,450 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 181 | 12% |
| Spain | 136 | 9% |
| United Kingdom | 83 | 6% |
| Mexico | 50 | 3% |
| India | 42 | 3% |
| Canada | 26 | 2% |
| Colombia | 23 | 2% |
| Japan | 22 | 2% |
| Philippines | 20 | 1% |
| Other | 275 | 19% |
| Unknown | 592 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1029 | 71% |
| Practitioners (doctors, other healthcare professionals) | 235 | 16% |
| Scientists | 164 | 11% |
| Science communicators (journalists, bloggers, editors) | 22 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 558 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 558 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 50 | 9% |
| Researcher | 44 | 8% |
| Unspecified | 42 | 8% |
| Student > Bachelor | 37 | 7% |
| Student > Ph. D. Student | 34 | 6% |
| Other | 127 | 23% |
| Unknown | 224 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 211 | 38% |
| Unspecified | 42 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 4% |
| Nursing and Health Professions | 10 | 2% |
| Biochemistry, Genetics and Molecular Biology | 9 | 2% |
| Other | 42 | 8% |
| Unknown | 220 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1479. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2024.
All research outputs
#8,257
of 25,807,758 outputs
Outputs from New England Journal of Medicine
#421
of 32,691 outputs
Outputs of similar age
#251
of 442,960 outputs
Outputs of similar age from New England Journal of Medicine
#12
of 271 outputs
Altmetric has tracked 25,807,758 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,691 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,960 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 271 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.